Your session is about to expire
← Back to Search
Radiprodil for GRIN Disorders
Study Summary
This trial aims to test the safety and effectiveness of radiprodil for treating a specific genetic disorder in children. All participants will receive radiprodil in the initial phase of the study lasting up
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals above the age of thirty eligible to enroll in this trial?
"This clinical investigation is open to participants aged over 6 months but under 12 years."
At how many different venues is this medical investigation currently accessible?
"Patients can enroll at various medical centers such as BC Children's Hospital in Vancouver, Ontario; Queensland Children's Hospital in South Brisbane; Lazio; The Hospital for Sick Children (Sick Kids) in Toronto, Toscana. Additionally, there are 13 other locations where patients may also participate."
What is the current number of individuals eligible for enrollment in this clinical research study?
"Indeed, the details on clinicaltrials.gov affirm that patient recruitment is ongoing for this trial. Originally shared on March 7th, 2023, and last modified on April 15th, 2024, the study aims to enroll a total of 24 participants distributed among thirteen different locations."
What are the specific goals and objectives of this research study?
"The primary goal of this examination, to be evaluated during specific time points such as Titration Visit 1 at week 5 and various other visits up to Maintenance Visit 4 at week 20, is to assess the occurrence of Treatment-Emergent Adverse Events (TEAEs), Serious TEAEs (SAEs), TEAEs Leading to Discontinuation, and the intensity of these adverse events. Additional aims encompass evaluating Clinical Global Impression of Change [CGI-C], Pediatric Quality of Life Inventory [PedsQL], and Caregiver Global Impression of Change (CaGI-C) as secondary endpoints."
What is the safety profile of Radiprodil for human use?
"Radiprodil's safety rating is 1 according to our team at Power, as this trial falls under Phase 1 with minimal existing data on both its efficacy and safety."
Are there any ongoing opportunities for patients to participate in this medical study?
"As indicated on clinicaltrials.gov, the current focus is on identifying suitable participants for this research endeavor. The study was initially shared with the public on March 7th, 2023 and received its latest update on April 15th, 2024."
Is it possible for individuals to participate in this clinical trial?
"- Cohort 2 individuals should exhibit significant behavioral and/or motor symptoms as reported by caregivers, with a Clinical Global Impression–Severity (CGI-S) score of ≥4."
Share this study with friends
Copy Link
Messenger